Correspondence 0001999371-24-012467 from Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals Holding Corp.
Date: Sept. 26, 2024 · CIK: 0001430306 · Accession: 0001999371-24-012467

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

September 20, 2024

Author

Very

Form

CORRESP

Company

Tonix Pharmaceuticals Holding Corp.

Letter

Tonix Pharmaceuticals Holding Corp.

Main Street, Suite 101

Chatham, New Jersey 07928

September 26, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Re: Tonix Pharmaceuticals Holding Corp.

Registration Statement on Form S-3 (File No. 333- 282270)

Filed on September 20, 2024

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on September 30, 2024, or as soon as practicable thereafter.

Please call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.

Very
truly yours,
TONIX PHARMACEUTICALS HOLDINGS CORP.

Show Raw Text

CORRESP
1
filename1.htm

Tonix
Pharmaceuticals Holding Corp.

26
Main Street, Suite 101

Chatham,
New Jersey 07928

September
26, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

 Re: Tonix
                                            Pharmaceuticals Holding Corp.

    Registration
                                            Statement on Form S-3 (File No. 333- 282270)

    Filed
                                            on September 20, 2024

Ladies and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced
Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission
at 4:00 p.m., Eastern Time, on September 30, 2024, or as soon as practicable thereafter.

Please
call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.

  Very
truly yours,

  TONIX PHARMACEUTICALS HOLDINGS CORP.

  By:
  /s/ Bradley Saenger

  Name:
  Bradley Saenger

  Title:
  Chief Financial Officer

SecProbe.io